Graham Capital Management, L.P. Tg Therapeutics, Inc. Transaction History

Graham Capital Management, L.P.

  • $4.42 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$13.02 - $21.3 $576,512 - $943,142
44,279 New
44,279 $673,000
Q3 2023

Nov 22, 2023
BUY
$8.36 - $26.5 $159,383 - $505,222
19,065 New
19,065 $159,000
Q3 2022

Nov 14, 2022
BUY
$4.57 - $8.4 $323,651 - $594,896
70,821 Added 54.69%
200,313 $1.19 Million
Q2 2022

Aug 15, 2022
BUY
$3.74 - $10.66 $484,300 - $1.38 Million
129,492 New
129,492 $550,000

Others Institutions Holding TGTX

# of Institutions
338
Shares Held
88.3M
Call Options Held
2.35M
Put Options Held
1.7M
View Full List

About TG THERAPEUTICS, INC.

TGTX Quotes by TradingView
  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.29B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Graham Capital Management, L.P. Portfolio

Follow Graham Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Graham Capital Management, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email